Consider aspirin: new draft colorectal cancer guidelines

Low-dose aspirin should be considered for people aged 50-70 years who are at average risk of colorectal cancer, according to new draft guidelines released by the Cancer Council.

The guidelines state that a low dose of aspirin is recommended for at least 2.5 years, commencing at age 50 to 70 years, and the benefit may extend to older ages with longer duration of use.

The guidelines also state that the evidence backs screening for bowel cancer by a faecal occult blood test every two years, starting at age 50 and continuing to age 74 years, but that use of flexible sigmoidoscopy as a primary screening test in the average-risk population is not recommended.

The guidelines are open for public comment until 8 April.

Read more

Clinical practice guidelines for the prevention, early detection and management of colorectal cancer 

Leave a Reply